✦ LIBER ✦

The synthesis of mevalonic acid by non-particulate avian and mammalian enzyme systems

✍ Scribed by Jonathan Brodie; John W. Porter

Book ID: 118847416
Publisher: Elsevier Science
Year: 1960
Tongue: English
Weight: 233 KB
Volume: 3
Category: Article
ISSN: 0006-291X
DOI: 10.1016/0006-291x(60)90217-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Particulate Enzyme System for the Synthe

Particulate Enzyme System for the Synthesis of Squalene from 2-(14C)-Mevalonic Acid

✍ GOSSELIN, L.; PODBER-WAGNER, E.; WALTREGNY, A. 📂 Article 📅 1962 🏛 Nature Publishing Group 🌐 English ⚖ 217 KB

Occurrence and Properties of Enzymes Ass

Occurrence and Properties of Enzymes Associated with Mevalonic Acid Synthesis in the Orange

✍ V. H. POTTY 📂 Article 📅 1969 🏛 Institute of Food Technologists 🌐 English ⚖ 554 KB

Fatty acid synthesis in rat liver: Relat

Fatty acid synthesis in rat liver: Relative contributions of the mitochondrial, microsomal and non-particulate systems

✍ W.E. Donaldson; E.M. Wit-Peeters; H.R. Scholte 📂 Article 📅 1970 🏛 Elsevier Science 🌐 English ⚖ 658 KB

On the mechanism of incorporation of ade

On the mechanism of incorporation of adenylic acid from adenosine triphosphate into ribonucleic acid by soluble mammalian enzyme systems

✍ E.S. Cabellakis 📂 Article 📅 1957 🏛 Elsevier Science ⚖ 112 KB

The mechanism of synthesis of fatty acid

The mechanism of synthesis of fatty acids by the pigeon liver enzyme system

✍ G.T. Phillips; J.E. Nixon; Judith A. Dorsey; P.H.W. Butterworth; C.J. Chesterton 📂 Article 📅 1970 🏛 Elsevier Science 🌐 English ⚖ 892 KB

Structure-Based Design and Synthesis of

Structure-Based Design and Synthesis of the First Weak Non-Phosphate Inhibitors for IspF, an Enzyme in the Non-Mevalonate Pathway of Isoprenoid Biosynthesis

✍ Corinne Baumgartner; Christian Eberle; François Diederich; Susan Lauw; Felix Roh 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 German ⚖ 583 KB

## Abstract In this paper, we describe the structure‐based design, synthesis, and biological evaluation of cytosine derivatives and analogues that inhibit IspF, an enzyme in the non‐mevalonate pathway of isoprenoid biosynthesis. This pathway is responsible for the biosynthesis of the C~5~ precursor